Astepro patent granted
- [December 6, 2011]

Dymista Filed with FDA
- [April, 2011]

Positive Study Results Presented
- [March, 2011]

MEDA introduces EDLUAR^TM, the first and only sublingual tablet that contains the most prescribed sleep medication, zolpidem tartrate
- [September, 2009]

MEDA receives FDA approval of new ASTEPRO^® (azelastine HCl) nasal spray 0.15%, the first and only once-daily nasal antihistamine
- [September, 2009]

FDA approval for Onsolis anticipated during summer 2009
- [June, 2009]

Positive study supporting a potential once-daily nasal antihistamine
- [May, 2009]

Edluar receives FDA approval
- [March, 2009]

Further inquiries should be directed to info@meda.us